GILD FY 2015 Earnings Report — Gilead Sciences, Inc. Revenue & Financial Results | Market Cap Arena

Gilead Sciences, Inc.GILD

FY 2015 Earnings

Reported February 24, 2016

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	FY 2015	Prior Q	FY 2014	QoQ Change	YoY Change
Revenue	$32.6B	—	$24.9B	—	31.1%
Op. Income	$22.2B	—	$15.3B	—	45.4%
Gross Margin	87.7%	—	84.8%	—	2.9pp
Net Margin	55.5%	—	48.6%	—	6.9pp
EPS (Diluted)	$11.91	—	$7.35	—	62.0%
Free Cash Flow	$20.5B	—	$12.3B	—	67.2%

Revenue Flow

Item	Amount
REVENUE	$32.6B
Cost of Revenue	$4.0B
GROSS PROFIT	$28.6B
R&D Expenses	$3.0B
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$3.4B
Other Expenses	$0
Operating Expenses	$6.4B
Cost & Expenses	$10.4B
OPERATING INCOME	$22.2B
Interest Income	$0
Interest Expense	$688M
Other Income/Expenses	-$534M
INCOME BEFORE TAX	$21.7B
Income Tax Expense	$3.6B
Net Income from Continuing Ops	$18.1B
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$18.1B
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$18.1B
D&A	$1.1B
EBIT	$22.3B
EBITDA	$23.4B
EPS	$12
EPS Diluted	$12

Income Statement

Item	Amount
REVENUE	$32.6B
Cost of Revenue	$4.0B
GROSS PROFIT	$28.6B
R&D Expenses	$3.0B
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$3.4B
Other Expenses	$0
Operating Expenses	$6.4B
Cost & Expenses	$10.4B
OPERATING INCOME	$22.2B
Interest Income	$0
Interest Expense	$688M
Other Income/Expenses	-$534M
INCOME BEFORE TAX	$21.7B
Income Tax Expense	$3.6B
Net Income from Continuing Ops	$18.1B
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$18.1B
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$18.1B
D&A	$1.1B
EBIT	$22.3B
EBITDA	$23.4B
EPS	$12
EPS Diluted	$12

Cash Flow Statement

Item	Amount
Net Income	$18.1B
Depreciation & Amortization	$1.1B
Stock-Based Compensation	$382M
Deferred Income Tax	-$393M
Other Non-Cash Items	$562M
Change in Working Capital	$1.5B
OPERATING CASH FLOW	$21.3B
Capital Expenditure	-$747M
Acquisitions (Net)	$0
Purchases of Investments	-$17.2B
Sales/Maturities of Investments	$5.5B
Other Investing Activities	$0
NET CASH FROM INVESTING	-$12.5B
Net Debt Issuance	$9.7B
Common Stock Repurchased	-$10.0B
Common Dividends Paid	-$1.9B
Other Financing Activities	-$4.0B
NET CASH FROM FINANCING	-$5.9B
FREE CASH FLOW	$20.5B
Net Change in Cash	$2.8B

Balance Sheet

Item	Amount
Cash & Equivalents	$12.9B
Short-Term Investments	$1.8B
Net Receivables	$5.9B
Inventory	$2.0B
Other Current Assets	$1.3B
TOTAL CURRENT ASSETS	$24.8B
PP&E (Net)	$2.3B
Goodwill	$1.2B
Intangible Assets	$10.2B
Long-Term Investments	$11.6B
Tax Assets	$324M
Other Non-Current Assets	$1.3B
TOTAL NON-CURRENT ASSETS	$27.0B
TOTAL ASSETS	$51.7B
Account Payables	$1.2B
Short-Term Debt	$982M
Deferred Revenue	$440M
Other Current Liabilities	$380M
TOTAL CURRENT LIABILITIES	$9.9B
Long-Term Debt	$21.1B
Deferred Revenue NC	$0
Deferred Tax Liabilities	$0
Other Non-Current Liabilities	$1.6B
TOTAL NON-CURRENT LIABILITIES	$22.7B
TOTAL LIABILITIES	$32.6B
Common Stock	$1M
Additional Paid-In Capital	$444M
Retained Earnings	$18.0B
Treasury Stock	$0
Accum. Other Comp. Income	$88M
Other Equity	$0
TOTAL STOCKHOLDERS' EQUITY	$18.5B
Minority Interest	$579M
TOTAL EQUITY	$19.1B
TOTAL LIABILITIES & EQUITY	$51.7B
Total Debt	$22.1B
Net Debt	$9.2B